Literature DB >> 20467416

MISSION esiRNA for RNAi screening in mammalian cells.

Mirko Theis1, Frank Buchholz.   

Abstract

RNA interference (RNAi) is a basic cellular mechanism for the control of gene expression. RNAi is induced by short double-stranded RNAs also known as small interfering RNAs (siRNAs). The short double-stranded RNAs originate from longer double stranded precursors by the activity of Dicer, a protein of the RNase III family of endonucleases. The resulting fragments are components of the RNA-induced silencing complex (RISC), directing it to the cognate target mRNA. RISC cleaves the target mRNA thereby reducing the expression of the encoded protein(1,2,3). RNAi has become a powerful and widely used experimental method for loss of gene function studies in mammalian cells utilizing small interfering RNAs. Currently two main methods are available for the production of small interfering RNAs. One method involves chemical synthesis, whereas an alternative method employs endonucleolytic cleavage of target specific long double-stranded RNAs by RNase III in vitro. Thereby, a diverse pool of siRNA-like oligonucleotides is produced which is also known as endoribonuclease-prepared siRNA or esiRNA. A comparison of efficacy of chemically derived siRNAs and esiRNAs shows that both triggers are potent in target-gene silencing. Differences can, however, be seen when comparing specificity. Many single chemically synthesized siRNAs produce prominent off-target effects, whereas the complex mixture inherent in esiRNAs leads to a more specific knockdown(10). In this study, we present the design of genome-scale MISSION esiRNA libraries and its utilization for RNAi screening exemplified by a DNA-content screen for the identification of genes involved in cell cycle progression. We show how to optimize the transfection protocol and the assay for screening in high throughput. We also demonstrate how large data-sets can be evaluated statistically and present methods to validate primary hits. Finally, we give potential starting points for further functional characterizations of validated hits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467416      PMCID: PMC3152863          DOI: 10.3791/2008

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Expression profiling reveals off-target gene regulation by RNAi.

Authors:  Aimee L Jackson; Steven R Bartz; Janell Schelter; Sumire V Kobayashi; Julja Burchard; Mao Mao; Bin Li; Guy Cavet; Peter S Linsley
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

3.  DEQOR: a web-based tool for the design and quality control of siRNAs.

Authors:  Andreas Henschel; Frank Buchholz; Bianca Habermann
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Minimizing the risk of reporting false positives in large-scale RNAi screens.

Authors:  Christophe J Echeverri; Philip A Beachy; Buzz Baum; Michael Boutros; Frank Buchholz; Sumit K Chanda; Julian Downward; Jan Ellenberg; Andrew G Fraser; Nir Hacohen; William C Hahn; Aimee L Jackson; Amy Kiger; Peter S Linsley; Lawrence Lum; Yong Ma; Bernard Mathey-Prévôt; David E Root; David M Sabatini; Jussi Taipale; Norbert Perrimon; René Bernards
Journal:  Nat Methods       Date:  2006-10       Impact factor: 28.547

5.  Genome-scale RNAi profiling of cell division in human tissue culture cells.

Authors:  Ralf Kittler; Laurence Pelletier; Anne-Kristine Heninger; Mikolaj Slabicki; Mirko Theis; Lukasz Miroslaw; Ina Poser; Steffen Lawo; Hannes Grabner; Karol Kozak; Jan Wagner; Vineeth Surendranath; Constance Richter; Wayne Bowen; Aimee L Jackson; Bianca Habermann; Anthony A Hyman; Frank Buchholz
Journal:  Nat Cell Biol       Date:  2007-11-11       Impact factor: 28.824

6.  Statistical practice in high-throughput screening data analysis.

Authors:  Nathalie Malo; James A Hanley; Sonia Cerquozzi; Jerry Pelletier; Robert Nadon
Journal:  Nat Biotechnol       Date:  2006-02       Impact factor: 54.908

7.  Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies.

Authors:  Ralf Kittler; Vineeth Surendranath; Anne-Kristin Heninger; Mikolaj Slabicki; Mirko Theis; Gabriele Putz; Kristin Franke; Antonio Caldarelli; Hannes Grabner; Karol Kozak; Jan Wagner; Effi Rees; Bernd Korn; Corina Frenzel; Christoph Sachse; Birte Sönnichsen; Jie Guo; Janell Schelter; Julja Burchard; Peter S Linsley; Aimee L Jackson; Bianca Habermann; Frank Buchholz
Journal:  Nat Methods       Date:  2007-03-11       Impact factor: 28.547

8.  RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells.

Authors:  Ralf Kittler; Laurence Pelletier; Chunling Ma; Ina Poser; Steffi Fischer; Anthony A Hyman; Frank Buchholz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-03       Impact factor: 11.205

Review 9.  Systems biology of mammalian cell division.

Authors:  Ralf Kittler; Laurence Pelletier; Frank Buchholz
Journal:  Cell Cycle       Date:  2008-05-21       Impact factor: 4.534

Review 10.  Small silencing RNAs: an expanding universe.

Authors:  Megha Ghildiyal; Phillip D Zamore
Journal:  Nat Rev Genet       Date:  2009-02       Impact factor: 53.242

  10 in total
  8 in total

Review 1.  RNAi screening: new approaches, understandings, and organisms.

Authors:  Stephanie E Mohr; Norbert Perrimon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-22       Impact factor: 9.957

2.  Increased Interferon-Induced Protein With Tetracopeptides (IFITs) Reduces Mycobacterial Growth.

Authors:  Abhilasha Madhvi; Hridesh Mishra; Novel N Chegou; Bienyameen Baker
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

3.  ATR expands embryonic stem cell fate potential in response to replication stress.

Authors:  Sina Atashpaz; Sara Samadi Shams; Javier Martin Gonzalez; Endre Sebestyén; Negar Arghavanifard; Andrea Gnocchi; Eliene Albers; Simone Minardi; Giovanni Faga; Paolo Soffientini; Elisa Allievi; Valeria Cancila; Angela Bachi; Óscar Fernández-Capetillo; Claudio Tripodo; Francesco Ferrari; Andrés Joaquin López-Contreras; Vincenzo Costanzo
Journal:  Elife       Date:  2020-03-12       Impact factor: 8.140

4.  PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca2+ Entry Via STIM2 in MDA-MB-231 Cells.

Authors:  Carlos Cantonero; Ginés M Salido; Juan A Rosado; Pedro C Redondo
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

5.  siRNA Genome Screening Approaches to Therapeutic Drug Repositioning.

Authors:  Olivia Perwitasari; Abhijeet Bakre; S Mark Tompkins; Ralph A Tripp
Journal:  Pharmaceuticals (Basel)       Date:  2013-01-28

6.  Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers.

Authors:  Jin-Ah Kim; Ying Tan; Xian Wang; Xixi Cao; Jamunarani Veeraraghavan; Yulong Liang; Dean P Edwards; Shixia Huang; Xuewen Pan; Kaiyi Li; Rachel Schiff; Xiao-Song Wang
Journal:  Nat Commun       Date:  2016-10-03       Impact factor: 14.919

7.  Melanopsin, a Canonical Light Receptor, Mediates Thermal Activation of Clock Genes.

Authors:  Maria Nathália Moraes; Leonardo Vinícius Monteiro de Assis; Keila Karoline Magalhães-Marques; Maristela Oliveira Poletini; Leonardo Henrique Ribeiro Graciani de Lima; Ana Maria de Lauro Castrucci
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

Review 8.  [RNA interference library research progress and its application in cancer research].

Authors:  Ning Zhao; Li Cai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.